Revisiting [PtCl₂(cis-1,4-DACH)]: an underestimated antitumor drug with potential application to the treatment of oxaliplatin-refractory colorectal cancer.
about
Recent Progress in Treating Protein-Ligand Interactions with Quantum-Mechanical MethodsEncapsulation of lipophilic kiteplatin Pt(iv) prodrugs in PLGA-PEG micelles.Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeutics.Enhanced semiempirical QM methods for biomolecular interactions.trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.Cisplatin, Oxaliplatin, and Kiteplatin Subcellular Effects Compared in a Plant Model.Computational evidence for structural consequences of kiteplatin damage on DNA.Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA.Synthesis, structural characterization, VHPO mimicking peroxidative bromination and DNA nuclease activity of oxovanadium(V) complexes.Combining the platinum(ii) drug candidate kiteplatin with 1,10-phenanthroline analogues.PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features.Hydroxyapatite nanocrystals as a smart, pH sensitive, delivery system for kiteplatin.DNA fragment conformations in adducts with KiteplatinSynthesis and Crystal Structure of trans-Diiodobis(piperidine-1-carbonitrile)platinum(II)Reactivity of kiteplatin with S-donor biomolecules and nucleotides
P2860
Q26747700-09E57A3A-8072-4F7B-9444-96A37020DB11Q35993977-0C5800E3-9BC7-410D-8D98-9E989C287480Q37093336-D3681FD7-0437-4A0E-8D28-C2AC755AE3D7Q38408928-C8112596-46D4-4CD2-AE0D-A54DA427EA77Q39006039-B7F5501D-5A38-44F5-A89B-52096A465ED6Q42317364-189DCEC8-A881-4629-AC99-8C936F394817Q44712236-BCA8297F-DEE1-44FA-B940-6B71A267FDBAQ46296200-B9F2BD1A-804A-4F8D-ACDA-03EED53F795AQ46803100-693855DA-F5B4-4950-B665-DF2975008AAEQ48205116-35ADD53E-4D7A-4605-9525-A2D464C90E40Q48205380-FFBCA2F9-19C9-4997-80AB-D1F39210AFCCQ53778083-2EF1981A-CCDD-4171-B361-78833B49EB43Q58486626-DE67F62A-50AA-4D9E-9CBC-CB70F3A1A0D0Q59012291-828819C1-06E6-4137-8279-178BBFDFA02DQ59172303-96BD1E64-43BA-44C6-B6DF-E0D45A2098D3
P2860
Revisiting [PtCl₂(cis-1,4-DACH)]: an underestimated antitumor drug with potential application to the treatment of oxaliplatin-refractory colorectal cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Revisiting [PtCl₂(cis-1,4-DACH ...... -refractory colorectal cancer.
@en
Revisiting [PtCl₂(cis-1,4-DACH ...... -refractory colorectal cancer.
@nl
type
label
Revisiting [PtCl₂(cis-1,4-DACH ...... -refractory colorectal cancer.
@en
Revisiting [PtCl₂(cis-1,4-DACH ...... -refractory colorectal cancer.
@nl
prefLabel
Revisiting [PtCl₂(cis-1,4-DACH ...... -refractory colorectal cancer.
@en
Revisiting [PtCl₂(cis-1,4-DACH ...... -refractory colorectal cancer.
@nl
P2093
P50
P356
P1476
Revisiting [PtCl₂(cis-1,4-DACH ...... n-refractory colorectal cancer
@en
P2093
Cristina Marzano
Emanuele Petruzzella
James D Hoeschele
P304
P356
10.1021/JM3006838
P407
P50
P577
2012-08-10T00:00:00Z